Recent Finacing
Recent Raise
Arkuda Therapeutics is a Massachusetts biotech developing medicines that correct progranulin deficiency and lysosomal dysfunction by leveraging lysosomal and microglial biology to treat GRN-related frontotemporal dementia and related neurodegeneration.
